Karjeras iespējas
Atklājiet darba iespējas Novartis. Lai atrastu papildu Novartis Gene Therapies (agrāk AveXis) darba piedāvājumus, apmeklējiet GTx karjeras meklēšanas lapu.
Paziņojums pretendentiem uz darba piedāvājumiem ASV. Uzzināt vairāk
Showing 2375 results
- Sort by Sort ascending
- Amata nosaukums Sakārtot augošā secībā
- Darbības joma
- Atrašanās vieta
- Vietne
- Ievietošanas datums
| Amata nosaukums Sakārtot augošā secībā | Darbības joma | Atrašanās vieta | Vietne | Ievietošanas datums |
|---|---|---|---|---|
| Medical Science Liaison Manager, Dermatologie (w/m/d), Gebiet: Westfalen-Lippe Regulär (Außendienst), Full time | Universal Hierarchy Node | Germany | North Rhine-Westphalia (Novartis Pharma GmbH) | Apr. 11, 2025 |
| Vodja skupine klinične proizvodnje (m/ž/d) / Senior Manager Clinical Manufacturing (m/f/d) Regulär, Full time | Innovative Medicines | Slovenia | Mengeš | Apr. 11, 2025 |
| Vodja področja klinične proizvodnje (m/ž/d) / Associate Director Clinical Manufacturing - Sterility Assurance (m/f/d) Regulär, Full time | Innovative Medicines | Slovenia | Mengeš | Apr. 11, 2025 |
| Vodja področja klinične proizvodnje (m/ž/d) / Associate Director Clinical Manufacturing (m/f/d) Regulär, Full time | Innovative Medicines | Slovenia | Mengeš | Apr. 11, 2025 |
| SSO Study Start-up Manager Regular, Full time | Innovative Medicines | Australia | New South Wales (NSW) | Apr. 11, 2025 |
| Business Data Migration Expert – Finance Regular, Full time | CTS | India +Alternative Locations | Hyderabad (Office) | Apr. 11, 2025 |
| Facilities Engineer Regular, Full time | Innovative Medicines | USA | Indianapolis | Apr. 11, 2025 |
| Technical Product Lead Regular, Full time | Pharma Research | India | Hyderabad (Office) | Apr. 11, 2025 |
| Clinical Development Director - Dermatology Regular, Full time | Innovative Medicines | Ireland +Alternative Locations | Dublin (NOCC) | Apr. 11, 2025 |
| Tehnik vzdrževanja II (m/ž/d) - Maintenance Technician II (m/f/d) Regular, Full time | Innovative Medicines | Slovenia | Mengeš | Apr. 11, 2025 |